title: [Safety and efficacy of duodenal stenting for malignant gastric outlet obstruction].
abstract: Malignant gastric outlet obstruction( GOO) compromises the ability to eat and drink. Surgical gastrojejunostomy has long been the standard palliative procedure for patients with GOO. However, it might not be applicable for patients with a poor general condition. In Japan, duodenal stenting for malignant GOO has been covered by health insurance since April 2010. In our hospital, 5 patients with malignant GOO underwent duodenal stenting using a WallFlexTM stent( Boston Scientific Corporation). Subsequently, we evaluated the safety and efficacy of duodenal stenting for malignant GOO. Most of the patients in this study were elderly, had systemic inflammation, and were malnourished. We achieved 100% technical and clinical success rates. Four patients were discharged from the hospital. No major complications such as perforation were noted. The median survival time after stenting was 86 days. In conclusion, endoscopic duodenal stenting for malignant GOO is safe and effective, and it could be an option for palliative therapy.
authors.affiliation: Dept. of Surgery, Nishinomiya Municipal Central Hospital.
authors.forename: Yoshio
authors.initials: Y
authors.lastname: Oka
authors.forename: Kaoru
authors.initials: K
authors.lastname: Okada
authors.forename: Hisashi
authors.initials: H
authors.lastname: Uemura
authors.forename: Shigeru
authors.initials: S
authors.lastname: Nakane
authors.forename: Naozumi
authors.initials: N
authors.lastname: Higaki
authors.forename: Yasuhiro
authors.initials: Y
authors.lastname: Miyake
authors.forename: Masakazu
authors.initials: M
authors.lastname: Murakami
authors.forename: Hirohito
authors.initials: H
authors.lastname: Hayashida
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Ogawa
authors.forename: Riichiro
authors.initials: R
authors.lastname: Nezu
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D004386:Duodenum; D017219:Gastric Outlet Obstruction / Q000209:etiology / Q000628:therapy*; D006801:Humans; D008297:Male; D010166:Palliative Care; D011788:Quality of Life; D015607:Stents / Q000009:adverse effects; D013274:Stomach Neoplasms / Q000150:complications*